![Kimball Hall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kimball Hall
Chief Executive Officer at
INNOCOLL HOLDINGS PLC
Net worth: - $ as of 31/07/2026
Profile
Kimball Hall is Chief Executive Officer at Syntacoll GmbH since 2023.
Ms. Hall is President & Chief Executive Officer at Innocoll Biotherapeutics Holdings Ltd. since 2023.
Ms. Hall is Independent Director at Vera Therapeutics, Inc. since 2021.
Ms. Hall was President & Chief Operating Officer at Abzena Holdings Us LLC from 2020 to 2023.
Ms. Hall was President, Chief Operating Officer & Director at Abzena Ltd. Ms. Hall was Senior Vice President at Genentech, Inc. Ms. Hall was Vice President-Manufacturing at Amgen, Inc. Ms. Hall completed undergraduate education at the University of Washington.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Kimball Hall active positions
| Companies | Position | Start |
|---|---|---|
| VERA THERAPEUTICS, INC. | Director/Board Member | 14/12/2021 |
| INNOCOLL HOLDINGS PLC | Chief Executive Officer | 26/01/2023 |
Syntacoll GmbH
 Syntacoll GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | 26/01/2023 |
Former positions of Kimball Hall
| Companies | Position | End |
|---|---|---|
Abzena Holdings Us LLC | President | 01/01/2023 |
| AMGEN INC. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| ABZENA PLC | President | - |
Training of Kimball Hall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
41
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syntacoll GmbH
Syntacoll GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Abzena Ltd.
 Abzena Ltd. BiotechnologyHealth Technology Engages in discovery, development and manufactures biologics drugs | Health Technology |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Abzena Holdings Us LLC |
- Stock Market
- Insiders
- Kimball Hall
